Stock comparison
Integer
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ITGR
Integer
Market cap
$3.03B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ITGR | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 48D | 77B | LMAT |
| Benjamin Graham | 65B | 89A | LMAT |
| Philip Fisher | 34F | 81C | LMAT |
| Peter Lynch | 57C | 67B | LMAT |
| Joel Greenblatt | 38D | 56D | LMAT |
| Charlie Munger | 42D | 68D | LMAT |
| Terry Smith | 41D | 69D | LMAT |
Side-by-side metrics
| Metric | ITGR | LMAT |
|---|---|---|
| Market cap | $3.03B | $2.23B |
| P/E (TTM) | 21.3x | 37.1x |
| EV/EBIT | 20.9x | 36.6x |
| ROIC (TTM) | 5.35% | 9.43% |
| Gross margin | 23.31% | 72.39% |
| Net margin | 7.67% | 24.35% |
| Revenue CAGR 5y | 10.89% | 12.75% |
| EPS CAGR 5y | 1.22% | 19.04% |
| Debt / Equity | 0.8x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ITGR leads on
- EV/EBIT20.9xvs 36.6x+43%
- P/E (TTM)21.3xvs 37.1x+43%
- Market cap$3.03Bvs $2.23B+26%
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- EPS CAGR 5y19.04%vs 1.22%+94%
- Net margin24.35%vs 7.67%+69%
- Gross margin72.39%vs 23.31%+68%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.